Levomefolate MCC Objection – Notice to Members
Proposal to reschedule levomefolate (levomefolic acid)Limited timeframe to object (22 July 2022) Dear members At its 68th meeting on 26th April, the Medicines Classification Committee (MCC) discussed a proposal to reschedule Levomefolic acid, also known as 5-methyltetrahydrofolate (5-MTHF), the biologically active form of folate and the form found in circulation in the human body. This […]
Levomefolate MCC Objection – Notice to Members Read More »
